IW 373

June 7, 2026 Viktor Zarev 0 min read
  1. Ebola spreads in Congo, misinformation is part of it.
  2. WVU Health System moves toward buying Independence Health.
  3. HHS decertifies Hawaii Medicaid Fraud Unit.
  4. South Africa rolls out HIV shot.
  5. 1 in 5 U.S. adults denied doctor-recommended care.
  6. The World Cup vs. bugs, germs, and heat.
  7. FDA moves forward with abortion pill safety study.
  8. Clover Health’s win and Medicare Advantage star ratings.
  9. 21 large health systems growing bigger.
  10. Epic dismisses claims against SelfRx.
Get twice-weekly insights on the biggest stories shaping cardiology.

You might also like

Heart Failure July 4, 2000

How Earlier Hemodynamic Insight May Help Guide Heart Failure Management July 4, 2000

Heart failure continues to place a significant burden on patients and the healthcare system, with nearly 7 million Americans living with heart failure, with prevalence expected to reach nearly 9 million by 2030. Despite advances in guideline-directed medical therapy (GDMT), many patients still face high risks of hospitalization, mortality, and reduced quality of life.

Cardiology Pharmaceuticals July 17, 2026

Can Kerendia Handle the (Blood) Pressure? More Findings from FINEARTS-HF. July 17, 2026

One year after its FDA approval for HF treatment, a new FINEARTS-HF substudy shows Bayer’s Kerendia (finerenone) isn’t just impervious to BP differences, it could actually give a small leg up to patients with hypertension.

Cardiac Imaging July 16, 2026

Zero CAC And The Cost of CCTA-QPA July 16, 2026

The power of a zero CAC score is facing fresh scrutiny after new plaque analysis data presented at SCCT 2026 shows just how much noncalcified plaque confers its own cardiovascular risk, despite the software’s financial barriers.